1Henson JD,Neumann AA,Yeager TR,et al.Alternative lengthening of telomeres in mammalian cells[J].Oncogene,2002,21(4):598-610.
2Chang S,Khoo CM,Naylor ML,et al.Telomere-based crisis:functional differences between telomerase activation and ALT in tumor progression[J].Genes Dev,2003,17(1):88-100.
3Rudolph KL,Millard M,Bosenberg MW,et al.Telomere dysfunction and evolution of intestinal carcinoma in mice and humans[J].Nat Genet,2001,28(2):155-159.
4Stewart SA,Hahn WC,O'Connor BF,et al.Telomerase contributes to tumorigenesis by a telomere length-independent mechanism[J].Proc Natl Acad Sci U S A,2002,99(20):12606-12611.
5Hiyama E,Hiyama K.Clinical utility of telomerase in cancer[J].Oncogene,2002,21(4):643-649.
6Villa R,Folini M,Lualdi S,et al.Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells[J].FEBS Lett,2000,473(2):241-248.
7Folini M,Pennati M,Zaffaroni N.Targeting human telomerase by antisense 01igonucleotides and ribozymes[J].Curr Med Chem Anti-Canc Agents,2002,2(5):605-612.
8Koga S,Kondo Y,Komata T,et al.Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA[J].Gene Ther,2001,8(8):654-658.
9Ludwig A,Saretzki G,Holm PS,et al.Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial celis to inhibitors of topoisomerase[J].Cancer Res,2001,61(7):3053-3061.
10Tentori L,Portarena I,Barbarino M,et al.Inhibition of telomerase increases resistance of melanoma cells to temozolomide,but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor[J].Mol Pharmacol,2003,63(1):192-202.
